CA3122767C - Stereoselective total synthesis of noribogaine - Google Patents

Stereoselective total synthesis of noribogaine Download PDF

Info

Publication number
CA3122767C
CA3122767C CA3122767A CA3122767A CA3122767C CA 3122767 C CA3122767 C CA 3122767C CA 3122767 A CA3122767 A CA 3122767A CA 3122767 A CA3122767 A CA 3122767A CA 3122767 C CA3122767 C CA 3122767C
Authority
CA
Canada
Prior art keywords
compound
formula
noribogaine
group
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3122767A
Other languages
English (en)
French (fr)
Other versions
CA3122767A1 (en
Inventor
Robert M. Moriarty
Deborah C. Mash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DemeRx Inc
Original Assignee
DemeRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DemeRx Inc filed Critical DemeRx Inc
Publication of CA3122767A1 publication Critical patent/CA3122767A1/en
Application granted granted Critical
Publication of CA3122767C publication Critical patent/CA3122767C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA3122767A 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine Active CA3122767C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161568568P 2011-12-08 2011-12-08
US61/568,568 2011-12-08
CA2856551A CA2856551C (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2856551A Division CA2856551C (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine

Publications (2)

Publication Number Publication Date
CA3122767A1 CA3122767A1 (en) 2013-06-13
CA3122767C true CA3122767C (en) 2023-03-28

Family

ID=48575047

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3122767A Active CA3122767C (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine
CA2856551A Active CA2856551C (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2856551A Active CA2856551C (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine

Country Status (10)

Country Link
US (2) US8937061B2 (https=)
EP (1) EP2788355A4 (https=)
JP (1) JP2015509076A (https=)
CN (1) CN104364256A (https=)
CA (2) CA3122767C (https=)
HK (1) HK1204604A1 (https=)
IL (1) IL232724A (https=)
IN (1) IN2014CN04160A (https=)
WO (1) WO2013085850A2 (https=)
ZA (1) ZA201403995B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
EP2595632A1 (en) 2010-07-23 2013-05-29 DemeRx, Inc. Noribogaine compositions
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA3122767C (en) 2011-12-08 2023-03-28 Demerx, Inc. Stereoselective total synthesis of noribogaine
EP2807167A4 (en) * 2012-01-25 2016-01-20 Demerx Inc INDOIND AND BENZO FURANKED ISOCHINUCLIDEN DERIVATIVES AND METHOD FOR THE MANUFACTURE THEREOF
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine
CA2942638C (en) 2013-03-15 2026-03-10 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone
JP2017509612A (ja) 2014-02-18 2017-04-06 デメルクス,インコーポレイテッド 薬物中毒の急性および長期間での治療方法。
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9345711B2 (en) 2014-02-18 2016-05-24 Demerx, Inc. Methods for acute and long-term treatment of drug addiction
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
CA2989550C (en) 2014-06-18 2023-08-08 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
AU2015353414B2 (en) 2014-11-26 2021-04-29 Demerx, Inc. Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
KR20220009954A (ko) 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
KR20250065690A (ko) 2022-09-14 2025-05-13 더 보드 오브 트러스티스 오브 더 릴랜드 스탠포드 주니어 유니버시티 이보가 알칼로이드의 조성물 및 치료 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813873A (en) * 1957-11-19 Derivatives of the ibogaine alkaloids
US3639408A (en) * 1967-06-03 1972-02-01 Shionogi & Co Process for the preparation of isoquinuclidine derivatives
MX9701430A (es) 1994-07-25 1997-12-31 Nda Int Inc Un metodo de tratamiento de dependencia quimica en mamiferos y una composicion para el mismo.
US5616575A (en) * 1995-12-04 1997-04-01 Regents Of The University Of Minnesota Bioactive tricyclic ibogaine analogs
US7220737B1 (en) * 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
EP1009407B1 (en) * 1997-09-04 2004-04-28 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
CN102225937B (zh) * 2011-05-04 2012-07-25 中国科学院昆明植物研究所 抗肿瘤生物碱类化合物,其药物组合物及其制备方法和应用
CA3122767C (en) 2011-12-08 2023-03-28 Demerx, Inc. Stereoselective total synthesis of noribogaine

Also Published As

Publication number Publication date
US9403837B2 (en) 2016-08-02
ZA201403995B (en) 2016-09-28
HK1204604A1 (en) 2015-11-27
EP2788355A2 (en) 2014-10-15
WO2013085850A2 (en) 2013-06-13
CA2856551C (en) 2021-06-22
US20130165647A1 (en) 2013-06-27
CA3122767A1 (en) 2013-06-13
CA2856551A1 (en) 2013-06-13
JP2015509076A (ja) 2015-03-26
US8937061B2 (en) 2015-01-20
IN2014CN04160A (https=) 2015-07-17
WO2013085850A3 (en) 2014-12-18
EP2788355A4 (en) 2015-10-21
CN104364256A (zh) 2015-02-18
IL232724A (en) 2017-07-31
IL232724A0 (en) 2014-08-03
US20150005492A1 (en) 2015-01-01

Similar Documents

Publication Publication Date Title
CA3122767C (en) Stereoselective total synthesis of noribogaine
EP1539764B1 (en) Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists.
EP1233964B1 (en) New use and novel n-azabicyclo-amide derivatives
JP5465241B2 (ja) 5−ht3受容体調節物質ならびにその作製方法および使用
AU2009342654B2 (en) Morphinan derivatives with high oral bioavailability
EP1414819A1 (en) THERAPEUTIC 1H-PYRIDO 4,3-b]INDOLES
WO2013085922A1 (en) Phosphate esters of noribogaine
HUT60270A (en) Process for producing alpha-oxoacetamide derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
AU2012209332A1 (en) Methods and compositions for preparing noribogaine from voacangine
BRPI0619705A2 (pt) composto, composição farmacêutica, método para ligar receptores a opióide num paciente, método para tratar disfunção gastrointestinal, método para tratar ìleo, método para tratar obesidade, método para tratar um efeito colateral associado com um opióide composto e método para tratar dor
JP5123429B2 (ja) インドリン抗癌剤
MXPA00012248A (es) Incrementadores de acetilcolina.
AU2010214685C1 (en) Noribogaine compositions
AU2012202509B2 (en) Noribogaine compositions
Ramakrishnan et al. Synthesis and biological evaluation of a metazocine-containing enkephalinamide. Evidence for nonidentical roles of the tyramine moiety in opiates and opioid peptides
WO1993007871A1 (en) Methods for the treatment of hyperlipidemia using azaspiranes
WO2026076497A1 (en) Structurally simplified analogues of lsd for the treatment of cns disorders
US5455247A (en) Methods for the treatment of hyperlipidemia using azaspiranes
WO1994009007A1 (en) 3a,6-bridged octahydroisoindoles and related hydroisoquinolines and hydrobenzazepines and their use as pharmaceutical and radioimaging agents
HK40025994A (en) Salt of phenylpropionamide derivative and preparation method therefor
HK40025994B (en) Salt of phenylpropionamide derivative and preparation method therefor
HK1147035B (en) Indoline anti-cancer agents

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210617

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241125

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241125

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241125

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD

Year of fee payment: 13

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251124

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251124